Alembic Pharma shares hit 52-week high after Gujarat plant clears USFDA inspection

October 9, 2024
Uncategorized

The maker of pharmaceutical inputs and bulk drugs said there was no Form 483 observation after the USFDA inspection of its plant in Gujarat this week.

Alembic Pharma shares hit 52-week high after Gujarat plant clears USFDA inspection

Leave a ReplyCancel Reply

Shiprocket files confidential DRHP with SEBI to raise nearly ₹2,500 crore in IPO: Sources

GMM Pfaudler posts ₹27-crore Q4 loss before one-time costs; declares dividend

Mankind Pharma Q4 Results: Profit drops, revenue surges 27% on-year

TeamLease Q4 profit rises 35% on improved operating efficiency, margins improve

Hindustan Zinc wins bid for 308.3-hectare tungsten block in Andhra Pradesh